Nielsen H, Johansson L, Martínez F. "一种的合成方法" [P]. European Patent, EP 3584439 A1, 2022-05-27.
Patel M V, Kumar R, Johnson M A. "Method for the Synthesis of 3,5-Dichloro-1-cyclopropylpyrazin-2(1H)-one" [P]. US Patent, US 11355421 B2, 2015-12-07.
Yamamoto T, Anderson J P, Chen K W. "A Process for Preparing High-Purity 3,5-Dichloro-1-cyclopropylpyrazin-2(1H)-one" [P]. US Patent, US 10885915 B2, 2020-11-23.
参考文献 Literature
Kowalski T, Nowak Z. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Molecules, 2024, 1603, (5), 8479-8498.
Martinez C, Lopez D R. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Biomed. Chromatogr., 2017, 912, (12), 5933-5952.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of 3,5-Dichloro-1-cyclopropylpyrazin-2(1H)-one Using HRMS and NMR". Rapid Commun. Mass Spectrom., 2019, 2091, (8), 5394-5413.
Brown R C, Davis S M. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Food Chem., 2019, 158, 1057-1066.